Search - tctmd.com

Displaying 21 - 40 of 221

Sort: Relevancy | Date

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Age-Related Macular Degeneration Linked to Severe Vascular Disease

Caitlin E. Cox

November 18, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

Podcast Rox Heart Radio

Rox Heart Radio: The Best of AHA

November 16, 2022

News Daily News

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

Todd Neale

November 16, 2022

News Daily News

New Risk Models Superior to Pretest Probability at Predicting CAD

Yael L. Maxwell

November 15, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

Todd Neale

November 14, 2022

Podcast TCTMD Talking Points

AMULET-IDE: One-Year Outcomes

November 09, 2022

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

News Conference News AHA 2022

Botulinum Toxin Injections No Help for Postoperative AF: NOVA

Yael L. Maxwell

November 07, 2022

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Shelley Wood

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

Yael L. Maxwell

November 05, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

Podcast TCTMD Talking Points

Shock Classification Gets an Update

November 02, 2022

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

Advertisement

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Age-Related Macular Degeneration Linked to Severe Vascular Disease

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Rox Heart Radio: The Best of AHA

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

New Risk Models Superior to Pretest Probability at Predicting CAD

Many STEMI Patients Not Treated Within National Time Goals

Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START

AMULET-IDE: One-Year Outcomes

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Botulinum Toxin Injections No Help for Postoperative AF: NOVA

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Shock Classification Gets an Update

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

November 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content